Return to Main Site 617-919-3019
401 Park Drive, 7th Floor East, Boston, MA 02215

TIDO Technology Search



Invention Type

Diagnostic/Prognostic
Information Technology/Software
Medical Device
Other
Research Tool
Therapeutics

Research Area

Allergy/Respiratory/Pulmonary Disease
Anesthesia
Audiology
Cardiovascular/Cardiology
Degenerative Disease
Dermatology
Endocrinology
Gastrointestinal/Nutrition
Genetic Disease
Health Care Management
Immunology
Infectious Disease
Inflammation
Internal Medicine
Metabolic Disease
Musculoskeletal
Neonatology/Pediatric
Neurology/Neuroscience
Oncology/Hematology
Ophthalmology
Orthopedics
Otolaryngology/Audiology
Pain
Pathology
Personalized Medicine
Psychiatric Disease
Radiology
Regenerative Medicine
Reproduction/Ob-Gyn
Stem Cell
Surgery/Wound Healing
Urology
CMCC 2572

Conversion of somatic cells into nociceptors

Inventors: Clifford Woolf, Brian Wainger, Kevin Eggan, Isaac Chiu, Justin Ichida

Invention Types: Research Tool, Therapeutics

Research Areas: Neurology/Neuroscience, Pain

Keywords: Assay

For More Information Contact:  Caron, Connie

 

Invention Description:

Nociceptors are the first-order neuron in the pain sensory transduction pathway and play the critical first step in the detection of noxious stimuli (nociception) and in the development of inflammatory and neuropathic pain.


Researchers at Boston Children’s Hospital and Harvard have successfully identified methods of transdifferentiating somatic cells, (e.g., a fibroblast) into an induced nociceptor cell by increasing the protein expression of five nociceptor inducing factors. These induced nociceptors have characteristics of a typical noxious stimulus-detecting nociceptor cell. Nociceptors are generated from an expandable cell population, so that large numbers of cells can be easily produced, e.g. for screens - applications that require large scalability are not feasible with primary nociceptors.

Applications:

- Commercial kit for producing induced nociceptors.

- Drug screening using nociceptors in in vitro assays to identify compounds that may be used as anti-pain or neuropathy therapeutics.

- Drug screening to identify potential pain-producing side effect

Competitive Advantages:

- Nociceptors mimic pain receptors better than rodent models for investigating and predicting human disease phenotypes, i.e. analgesia.

- In vitro is faster than in vivo models

- Nociceptors can be reprogrammed from somatic cell, such as fibroblast ob

Business Opportunity:

Non-exclusive license for creating commercial research kits and for providing commercial services.

IPStatus: Pat. in Prep.